Why the study?
Does repeated administration of mouse brain interferon improve survival in mice infected with encephalomyocarditis virus?
Does repeated administration of mouse brain interferon improve survival in mice infected with encephalomyocarditis virus?
Repeated administration of interferon improves survival in mice infected with encephalomyocarditis virus, suggesting potential value in treating some viral diseases.
Prolonged interferon may enhance survival in murine viral models; leaves open translation to human therapy.
Administration of mouse brain interferon prior to or after inoculation of 100-250 LD50 of encephalomyocarditis (EMC) virus, conferred a significant degree of protection on weanling IC mice. Continuation of interferon treatment for several days after virial inoculation considerably increased the number of mice surviving infection. Most interferon protected mice did not develop HI antibody to EMC virus nor did they demonstrate resistance to viral rechallenge. By acting early in the course of viral infection interferon may have repressed viral multiplication below a level necessary to induce a specific immune response. Mice did not develop a “tolerance” to repeated inoculation of exogenous interferon. Considered together the experimental results suggested that continued interferon administration may prove of value in the treatment of some viral diseases.
No takes yet. Share an insight, caveat, or question.
Gresser et al. (1968) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: